Vertex Pharmaceutic (VRTX)

Apr 1, 2025, 2:01 PM EDT - 15 hours ago

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

ABBV AMGN BMY GILD LLY MRK MRNA

Mar 31, 2025, 2:05 PM EDT - 1 day ago

Stifel's Paul Matteis says look for biotech names not dependent on the FDA amid sector uncertainty

XBI ALNY RYTM XENE

Mar 28, 2025, 4:05 PM EDT - 4 days ago

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Mar 27, 2025, 5:14 PM EDT - 5 days ago

Final Trades: Vertex Pharma, Netflix and the IYF

NFLX IYF

Mar 27, 2025, 10:22 AM EDT - 5 days ago

Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector.

ABBV AMGN BIIB BMY GILD IHE JNJ

Mar 24, 2025, 1:19 PM EDT - 8 days ago

Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals

Mar 14, 2025, 1:48 PM EDT - 18 days ago

Evercore's "All-Weather" stock list: NRG Energy, Vistra, Vertex, IBM and ASML

ASML IBM NRG VST

Mar 11, 2025, 1:40 PM EDT - 21 days ago

Stocks beating the stock market's recent Trump slump have this in common

ABBV AMGN BAX CVS GILD PM SMCI

Mar 11, 2025, 1:32 PM EDT - 21 days ago

Final Trades: Netflix, Meta, Vertex, Interactive Brokers and the COWZ

IBKR META NFLX COWZ

Mar 11, 2025, 8:55 AM EDT - 21 days ago

Top 3 Health Care Stocks That May Keep You Up At Night In Q1

SNY TSVT

Mar 10, 2025, 3:00 PM EDT - 22 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Leerink's Global Healthcare Conference 2025 (Transcript)

Mar 7, 2025, 10:02 AM EST - 25 days ago

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Mar 6, 2025, 9:00 AM EST - 26 days ago

Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating

Mar 3, 2025, 6:41 PM EST - 4 weeks ago

Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 45th Annual Health Care Conference (Transcript)

Feb 28, 2025, 7:22 AM EST - 4 weeks ago

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Feb 27, 2025, 1:53 PM EST - 4 weeks ago

Trade Tracker: Rob Sechan sells McDonald's and Vertex, buys Texas Pacific Land, Amgen and NRG

AMGN MCD TPL NRG

Feb 18, 2025, 4:05 PM EST - 6 weeks ago

Vertex to Participate in Upcoming March Investor Conferences

Feb 18, 2025, 9:52 AM EST - 6 weeks ago

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

BLUE CVS

Feb 11, 2025, 2:21 PM EST - 7 weeks ago

Calls of the Day: Charles Schwab, Vertex Pharma and Transocean

RIG SCHW

Feb 11, 2025, 9:55 AM EST - 7 weeks ago

Vertex Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results

Feb 10, 2025, 8:26 PM EST - 7 weeks ago

Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript

Feb 10, 2025, 4:40 PM EST - 7 weeks ago

Vertex Pharmaceuticals' Revenue Forecast Tops Expectations

Feb 10, 2025, 4:14 PM EST - 7 weeks ago

Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand

Feb 10, 2025, 4:01 PM EST - 7 weeks ago

Vertex Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 10, 2025, 10:20 AM EST - 7 weeks ago

Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?

Feb 10, 2025, 7:24 AM EST - 7 weeks ago

Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings

Feb 5, 2025, 1:30 PM EST - 7 weeks ago

Final Trades: Energy Transfer, Vertex Pharma, UnitedHealth and Axon Enterprise

AXON ET UNH

Feb 1, 2025, 10:17 PM EST - 2 months ago

Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain

Feb 1, 2025, 8:00 AM EST - 2 months ago

Vertex: YOY Decline In Q4 Earnings Expected, But Revenue Continues To Shine

Jan 31, 2025, 1:50 PM EST - 2 months ago

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug

Jan 31, 2025, 11:39 AM EST - 2 months ago

FDA approves a new painkiller for the first time in decades

Jan 31, 2025, 10:36 AM EST - 2 months ago

Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval

Jan 31, 2025, 10:33 AM EST - 2 months ago

Vertex Pharmaceuticals CEO on non-opioid painkiller: It's safe, effective and non-addictive

Jan 31, 2025, 9:32 AM EST - 2 months ago

What's Happening With VRTX Stock?

Jan 31, 2025, 6:59 AM EST - 2 months ago

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Jan 31, 2025, 6:52 AM EST - 2 months ago

FDA approves Vertex's non-opioid painkiller - first new kind of pain medicine in decades

Jan 31, 2025, 4:35 AM EST - 2 months ago

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Jan 31, 2025, 2:00 AM EST - 2 months ago

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

Jan 30, 2025, 7:55 PM EST - 2 months ago

FDA Approves Non-Opioid Painkiller With No Addiction Risk

Jan 30, 2025, 6:25 PM EST - 2 months ago

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

Jan 30, 2025, 5:59 PM EST - 2 months ago

US FDA approves Vertex's non-opioid painkiller

Jan 30, 2025, 5:58 PM EST - 2 months ago

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades